CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
Omega-3 Supplementation +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02617511
NCT02617511N/ACompleted

Omega-3 Fatty Acid Supplementation and Resistance Training on Inflammation and Body Composition in Older Men

University of Manitoba·interventional·Posted Dec 1, 2015·Updated Sep 13, 2023

In Brief

A clinical study evaluating Omega-3 Supplementation and Placebo for Sarcopenia and 2 related conditions. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this project is to evaluate whether omega-3 fatty acid supplementation (combined eicosapentaenoic acid and docosahexaenoic acid \[EPA/DHA\] supplement) augments the effects of a 12-week resistance training program in older men. Outcome variables include inflammatory biomarkers in the systemic circulation, body composition and performance measures. The specific inflammatory markers in the blood include: C-reactive protein, tumor necrosis factor-α, interleukin-1β, and interleukin-6. Remaining parameters include: body composition (as assessed by dual energy x-ray absorptiometry), muscle strength (as assessed by chest press and leg press one-repetition maximum strength tests), and functional ability (as assessed by timed up and go test as well as the 6-minute walking test).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 1, 2015
Enrollment StartOct 1, 2015
Primary CompletionSep 1, 2016
Study CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.6 years ago

Interventions

Omega-3 Supplementationdietary

Placebodietary